Get started
Author

Malo Journou

Sustained Clinical Benefit of AAV Gene Therapy in Severe Hemophilia B
2025 · Ulrike M. Reiss, Andrew M. Davidoff, et al. · New England Journal of Medicine · 77
AAV8 locoregional delivery induces long-term expression of an immunogenic transgene in macaques despite persisting local inflammation
2021 · Gwladys Gernoux, Mickaël Guilbaud, et al. · Molecular Therapy — Methods & Clinical Development · 14
PDF
Incomplete elimination of viral genomes is associated with chronic inflammation in nonhuman primate livers after AAV-mediated gene transfer
2025 · Virginie Pichard, Mickaël Guilbaud, et al. · Gene Therapy · 10
PDF
Immune-driven gene expression loss following intramuscular AAV delivery to non-human primates is only transient
2025 · Malo Journou, Marie Devaux, et al. · Molecular Therapy — Methods & Clinical Development · 7
Intracellular accumulation of AAV6 genomes governs microglia reactivity and the inflammatory response in retinal gene therapy
2026 · Allwyn Pereira, Jean-Baptiste Ducloyer, et al. · bioRxiv (Cold Spring Harbor Laboratory)
PDF
OC 21.3 Epigenetic Determinants of AAV Transgene Expression in Human Liver Post Gene Therapy
2026 · Giulia Simini, Jenny McIntosh, et al. · Research and Practice in Thrombosis and Haemostasis
Decoding Transgene Silencing from Stably Maintained AAV Genomes in Human Liver: Epigenetic Insights to Guide Next-Generation Vector Design
2025 · Giulia Simini, Jenny McIntosh, et al. · Blood
Balance between rejection and tolerance : immune bipolarity of the skeletal muscle towards recombinant AAV
2021 · Journou, Malo · theses.fr (ABES)
Balance entre rejet et tolérance : la bipolarité immunitaire du muscle squelettique face à l’AAV recombinant : décryptage de la réponse immune de l’hôte dirigée contre le produit du transgène après injection de vecteurs AAV recombinants par voie intramusculaire
2021 · Malo Journou · theses.fr (ABES)
Works count: 9
Citation count: 108
H-index: 4
I10-index: 3
Year
Topic
Type